The articles listed on this page are from a variety of sources. 
1. The staff of DBS-STN often attends conferences or educational opportunities both nationally and internationally, and a brief understandable write-up of the information presented at the event will be provided for our readers to review. 
2. DBS-STN staff also identifies or writes various articles related to topics that are thought to be of interest for the reader of www.DBS-STN.org. 

Browse by Topic:
Search:

Completion of Clinical Trial for PRX-002 Developed by Prothena Corporation


(March 20, 2015) - A recently completed clinical trial for a new drug PRX-002, being developed by Prothena Corporation, has demonstrated a key ability to reduce the presence of alpha-synuclein, an enzyme thought to be associated with Parkinson's disease. Read more…



Article Archive

back